These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 11434720)
1. Helper T cell anergy: from biochemistry to cancer pathophysiology and therapeutics. Appleman LJ; Tzachanis D; Grader-Beck T; van Puijenbroek AA; Boussiotis VA J Mol Med (Berl); 2001; 78(12):673-83. PubMed ID: 11434720 [TBL] [Abstract][Full Text] [Related]
2. The ability of antigen, but not interleukin-2, to promote n-butyrate-induced T helper 1 cell anergy is associated with increased expression and altered association patterns of cyclin-dependent kinase inhibitors. Jackson SK; DeLoose A; Gilbert KM Immunology; 2002 Aug; 106(4):486-95. PubMed ID: 12153511 [TBL] [Abstract][Full Text] [Related]
3. p27kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes. Boussiotis VA; Freeman GJ; Taylor PA; Berezovskaya A; Grass I; Blazar BR; Nadler LM Nat Med; 2000 Mar; 6(3):290-7. PubMed ID: 10700231 [TBL] [Abstract][Full Text] [Related]
4. CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression. Appleman LJ; Berezovskaya A; Grass I; Boussiotis VA J Immunol; 2000 Jan; 164(1):144-51. PubMed ID: 10605005 [TBL] [Abstract][Full Text] [Related]
5. The cyclin-dependent kinase inhibitors p27Kip1 and p21Cip1 are not essential in T cell anergy. Verdoodt B; Blazek T; Rauch P; Schuler G; Steinkasserer A; Lutz MB; Funk JO Eur J Immunol; 2003 Nov; 33(11):3154-63. PubMed ID: 14579284 [TBL] [Abstract][Full Text] [Related]
6. Induction of immunologic tolerance for allogeneic hematopoietic cell transplantation. Appleman LJ; Tzachanis D; Grader-Beck T; Van Puijenbroek AA; Boussiotis VA Leuk Lymphoma; 2002 Jun; 43(6):1159-67. PubMed ID: 12152983 [TBL] [Abstract][Full Text] [Related]
7. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy. Wells AD; Walsh MC; Bluestone JA; Turka LA J Clin Invest; 2001 Sep; 108(6):895-903. PubMed ID: 11560959 [TBL] [Abstract][Full Text] [Related]
8. Altered T-cell receptor + CD28-mediated signaling and blocked cell cycle progression in interleukin 10 and transforming growth factor-beta-treated alloreactive T cells that do not induce graft-versus-host disease. Boussiotis VA; Chen ZM; Zeller JC; Murphy WJ; Berezovskaya A; Narula S; Roncarolo MG; Blazar BR Blood; 2001 Jan; 97(2):565-71. PubMed ID: 11154238 [TBL] [Abstract][Full Text] [Related]
9. Suppressor activity of anergic T cells induced by IL-10-treated human dendritic cells: association with IL-2- and CTLA-4-dependent G1 arrest of the cell cycle regulated by p27Kip1. Kubsch S; Graulich E; Knop J; Steinbrink K Eur J Immunol; 2003 Jul; 33(7):1988-97. PubMed ID: 12884865 [TBL] [Abstract][Full Text] [Related]
10. T cell effector function and anergy avoidance are quantitatively linked to cell division. Wells AD; Walsh MC; Sankaran D; Turka LA J Immunol; 2000 Sep; 165(5):2432-43. PubMed ID: 10946268 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation. Powell JD; Lerner CG; Schwartz RH J Immunol; 1999 Mar; 162(5):2775-84. PubMed ID: 10072524 [TBL] [Abstract][Full Text] [Related]
12. T cell hyporesponsiveness induced by oral administration of ovalbumin is associated with impaired NFAT nuclear translocation and p27kip1 degradation. Asai K; Hachimura S; Kimura M; Toraya T; Yamashita M; Nakayama T; Kaminogawa S J Immunol; 2002 Nov; 169(9):4723-31. PubMed ID: 12391180 [TBL] [Abstract][Full Text] [Related]
13. TCR engagement in the absence of cell cycle progression leads to T cell anergy independent of p27(Kip1). Powell JD; Bruniquel D; Schwartz RH Eur J Immunol; 2001 Dec; 31(12):3737-46. PubMed ID: 11745394 [TBL] [Abstract][Full Text] [Related]
14. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells. Appleman LJ; van Puijenbroek AA; Shu KM; Nadler LM; Boussiotis VA J Immunol; 2002 Mar; 168(6):2729-36. PubMed ID: 11884439 [TBL] [Abstract][Full Text] [Related]
15. Induction of anergy in Th1 cells associated with increased levels of cyclin-dependent kinase inhibitors p21Cip1 and p27Kip1. Jackson SK; DeLoose A; Gilbert KM J Immunol; 2001 Jan; 166(2):952-8. PubMed ID: 11145672 [TBL] [Abstract][Full Text] [Related]
16. Opposing roles for the cyclin-dependent kinase inhibitor p27kip1 in the control of CD4+ T cell proliferation and effector function. Rowell EA; Walsh MC; Wells AD J Immunol; 2005 Mar; 174(6):3359-68. PubMed ID: 15749868 [TBL] [Abstract][Full Text] [Related]
17. Differential association of protein tyrosine kinases with the T cell receptor is linked to the induction of anergy and its prevention by B7 family-mediated costimulation. Boussiotis VA; Barber DL; Lee BJ; Gribben JG; Freeman GJ; Nadler LM J Exp Med; 1996 Aug; 184(2):365-76. PubMed ID: 8760790 [TBL] [Abstract][Full Text] [Related]
18. Induction of global anergy rather than inhibitory Th2 lymphokines mediates posttrauma T cell immunodepression. De AK; Kodys KM; Pellegrini J; Yeh B; Furse RK; Bankey P; Miller-Graziano CL Clin Immunol; 2000 Jul; 96(1):52-66. PubMed ID: 10873428 [TBL] [Abstract][Full Text] [Related]
19. Peptide-induced anergy in allergen-specific human Th2 cells results in lack of cytokine production and B cell help for IgE synthesis. Reversal by IL-2, not by IL-4 or IL-13. Fasler S; Aversa G; Terr A; Thestrup-Pedersen K; de Vries JE; Yssel H J Immunol; 1995 Nov; 155(9):4199-206. PubMed ID: 7594575 [TBL] [Abstract][Full Text] [Related]
20. CD4+CD25+ regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy. Li L; Godfrey WR; Porter SB; Ge Y; June CH; Blazar BR; Boussiotis VA Blood; 2005 Nov; 106(9):3068-73. PubMed ID: 16020508 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]